HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 83 | 86 | 96.5% | |
| HF004 | 2020 | 129 | 130 | 99.2% | |
| HF006 | 2021 | 169 | 179 | 94.4% | |
| HF006 | 2022 | 171 | 182 | 94.0% | |
| HF006 | 2023 | 191 | 201 | 95.0% |
